The 15‐item Systemic Clinical Outcome and Routine Evaluation (SCORE‐15) Thai version was developed. This study aims to assess the test‐retest reliability and the criterion validity of the SCORE‐15 Thai version. The assessment of the test‐retest reliability was performed on twenty‐four non‐clinical participants who gave two ratings two to four weeks apart. Furthermore, sixty‐two clinical and seventy‐three non‐clinical subjects were included for the assessment of the criterion validity. The SCORE‐15 Thai version exhibited excellent test‐retest reliability with an intraclass correlation coefficient of 0.94. The validity study revealed that the effect sizes of score differences between clinical and non‐clinical groups were large (0.90–1.85). In conclusion, the SCORE‐15 Thai version can be a choice for routine clinical practice to determine family functioning in systemic family therapy.Practitioner points Assessment of family functioning is an essential process for both initial evaluations and monitoring the progress of family interventions The SCORE‐15 Thai version exhibited excellent test‐retest reliability and criterion validity The SCORE‐15 Thai version can be used as an instrument to determine family functioning in clinical practice and research

The SCORE-15 Thai version was developed for clinical use in Thailand. This study aims to assess the internal reliability of the SCORE-15 Thai version and its convergent validity with the Chulalongkorn Family Inventory (CFI), a measure modified from the Family Assessment Device (FAD), the perceptions of the family problems, and the mental health index. It exhibited a strong negative correlation with the CFI, a moderate negative correlation with the manageability rating and a weaker positive correlation with the severity rating. The internal reliability of both full-scale and subscales of the SCORE-15 was all good except for the communication subscale. The SCORE-15 also showed a discriminative pattern among participants with varying states of mental health. In conclusion, the SCORE-15 Thai version was generally a valid and reliable tool for family assessment in the clinical Thai population.

Objective: To investigate the prevalence of overweight and obesity in children and adolescents with ADHD and compare to other clinical samples. Method: A retrospective chart reviewing of 165 ADHD and 305 other clinical participants aged 6 to 18 years. Results: There was no statistically significant difference in terms of the prevalences of overweight and obesity between ADHD and other clinical participants. In ADHD group, the prevalences of overweight, obesity, and combined overweight/obesity were 15.8%, 20.0%, and 35.8%, respectively. In addition, male gender was significantly associated with increasing the prevalences of overweight and obesity in children and adolescents with ADHD. Conclusion: The prevalences of overweight and obesity between ADHD and other clinical samples were not different in a clinical setting. Male gender was significantly associated with increasing the prevalences of overweight and obesity in children and adolescents with ADHD.